Numeric Investors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Numeric Investors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-158,300	Closed	-$8.55M	–	1239
2017 Q3	$8.55M	Buy	158,300 +144,900	+1,081%	+$8.51M	0.07%	284
2017 Q2	$753K	Buy	+13,400	New	+$537K	0.01%	732
2016 Q4	–	Sell	-194,700	Closed	-$4.42M	–	1239
2016 Q3	$4.42M	Sell	194,700 -14,600	-7%	-$343K	0.04%	341
2016 Q2	$4.94M	Sell	209,300 -376,256	-64%	-$9.29M	0.04%	307
2016 Q1	$11.9M	Buy	585,556 +546,556	+1,401%	+$17.3M	0.13%	176
2015 Q4	$2.01M	Buy	+39,000	New	+$1.89M	0.02%	445
2015 Q2	–	Sell	-106,600	Closed	-$4.05M	–	1134
2015 Q1	$4.05M	Buy	+106,600	New	+$3.66M	0.05%	273
2014 Q4	–	Sell	-100,511	Closed	-$2.54M	–	1028
2014 Q3	$2.54M	Buy	+100,511	New	+$2.65M	0.04%	303
2014 Q2	–	Sell	-233,786	Closed	-$6.05M	–	946
2014 Q1	$6.05M	Buy	233,786 +70,964	+44%	+$1.89M	0.1%	203
2013 Q4	$4.19M	Buy	+162,822	New	+$3.96M	0.07%	241

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Numeric Investors's PTLA Position: Q4 2017 in Review

Numeric Investors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2017, closing a stake of 158,300 shares — an estimated $8.55M sold.

Numeric Investors first reported a position in PTLA in Q4 2013 and held it in 10 quarters. The position peaked at $11.9M in Q1 2016. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

Numeric Investors reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Numeric Investors sold 158,300 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $8.55M.
Numeric Investors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 10 quarters.
Numeric Investors's Portola Pharmaceuticals, Inc. position peaked at $11.9M in Q1 2016.
215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.